CD44+ EOC stem cells express pluripotency markers such as β-catenin, Oct-4, and SSEA-4 [14] and have been demonstrated to be the chemoresistant progenitors in vivo and are able to differentiate into the heterogenous cell types comprising the tumor [14, 22]. The gene discussed is CD44; the disease is neoplasm.